MedKoo product information:

PX-12

Thioredoxin-1 (Trx-1) is a small redox protein that is over-expressed in many human tumors, where it is associated with aggressive tumor growth and decreased patient survival. Trx-1 is secreted by tumor cells and is present at increased levels in the plasma of cancer patients. PX-12 is an irreversible inhibitor of Trx-1 currently in clinical development as an antitumor agent.The research results suggest that the lowering of elevated levels of plasma Trx-1 in cancer patients may provide a surrogate for the inhibition of tumor Trx-1 by PX-12. Furthermore, PX-12 decreases plasma VEGF levels which may contribute to the antitumor activity of PX-12. See: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1432091/.

Current developer:    Biomira Inc; Oncothyreon Inc.

1. Dal Piaz, F.; Braca, A.; Belisario, M. A.; De Tommasi, N. Thioredoxin system modulation by plant and fungal secondary metabolites. Current Medicinal Chemistry (2010), 17(5), 479-494. CODEN: CMCHE7 ISSN:0929-8673. CAN 152:396831 AN 2010:258754

2. Rickles, Richard; Lee, Margaret S.  -Adrenergic receptor agonists for the treatment of B-cell proliferative disorders. PCT Int. Appl. (2009), 111 pp. CODEN: PIXXD2 WO 2009151569 A2 20091217 CAN 152:67621 AN 2009:1566750

3. Witczak, Zbigniew J. 1,5-C-Thio-sugars as selective inhibitors of thioredoxins. Abstracts of Papers, 238th ACS National Meeting, Washington, DC, United States, August 16-20, 2009 (2009), CARB-128. CODEN: 69LVCL AN 2009:980954

4. Kirkpatrick, Lynn. Compositions and methods for using asymmetric disulfides for treating cancer. PCT Int. Appl. (2009), 39 pp. CODEN: PIXXD2 WO 2009082686 A1 20090702 CAN 151:93997 AN 2009:799277

5. Rickles, Richard; Lee, Margaret S. Use of adenosine A2A receptor agonists and phosphodiesterase (PDE) inhibitors for the treatment of B-cell proliferative disorders, and combinations with other agents. PCT Int. Appl. (2009), 70 pp. CODEN: PIXXD2 WO 2009011893 A2 20090122 CAN 150:160095 AN 2009:86451

6. Rickles, Richard; Pierce, Laura; Lee, Margaret S. Combinations for the treatment of B-cell proliferative disorders. PCT Int. Appl. (2009), 79pp. CODEN: PIXXD2 WO 2009011897 A1 20090122 CAN 150:160094 AN 2009:83374

7. Huber, Kelly; Patel, Poulam; Zhang, Lei; Evans, Helen; Westwell, Andrew D.; Fischer, Peter M.; Chan, Stephen; Martin, Stewart. 2-[(1-Methylpropyl)dithio]-1H-imidazole inhibits tubulin polymerization through cysteine oxidation. Molecular Cancer Therapeutics (2008), 7(1), 143-151. CODEN: MCTOCF ISSN:1535-7163. CAN 148:322142 AN 2008:64825

8. Ramanathan, Ramesh K.; Kirkpatrick, D. Lynn; Belani, Chandra P.; Friedland, David; Green, Sylvan B.; Chow, H-H. Sherry; Cordova, Catherine A.; Stratton, Steven P.; Sharlow, Elizabeth R.; Baker, Amanda; Dragovich, Tomislav. A Phase I Pharmacokinetic and Pharmacodynamic Study of PX-12, a Novel Inhibitor of Thioredoxin-1, in Patients with Advanced Solid Tumors. Clinical Cancer Research (2007), 13(7), 2109-2114. CODEN: CCREF4 ISSN:1078-0432. CAN 147:314431 AN 2007:369854

9. Galmarini, Carlos M. Drug evaluation: the thioredoxin inhibitor PX-12 in the treatment of cancer. Current Opinion in Investigational Drugs (Thomson Scientific) (2006), 7(12), 1108-1115. CODEN: COIDAZ ISSN:1472-4472. CAN 146:219923 AN 2007:71951

10. Kirkpatrick, Lynn; Pestano, Linda Anne. Determination of HIF-1 inhibitor treatment response. U.S. Pat. Appl. Publ. (2006), 28 pp., Cont.-in-part of U.S. Ser. No. 929,156. CODEN: USXXCO US 2006275836 A1 20061207 CAN 146:20274 AN 2006:1286049

11. Baker, Amanda F.; Dragovich, Tomislav; Tate, Wendy R.; Ramanathan, Ramesh K.; Roe, Denise; Hsu, Chiu-Hsieh; Kirkpatrick, D. Lynn; Powis, Garth. The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma. Journal of Laboratory and Clinical Medicine (2006), 147(2), 83-90. CODEN: JLCMAK ISSN:0022-2143. CAN 145:95883 AN 2006:110292

12. Jordan, Benedicte F.; Runquist, Matthew; Raghunand, Natarajan; Gillies, Robert J.; Tate, Wendy R.; Powis, Garth; Baker, Amanda F. The Thioredoxin-1 Inhibitor 1-Methylpropyl 2-Imidazolyl Disulfide (PX-12) Decreases Vascular Permeability in Tumor Xenografts Monitored by Dynamic Contrast Enhanced Magnetic Resonance Imaging. Clinical Cancer Research (2005), 11(2, Pt. 1), 529-536. CODEN: CCREF4 ISSN:1078-0432. CAN 142:385270 AN 2005:271357

13. Bergink, Arjan P.; van Meurs, Joyce B.; Loughlin, John; Arp, Pascal P.; Fang, Yue; Hofman, Albert; van Leeuwen, Johannes P. T. M.; van Duijn, Cornelia M.; Uitterlinden, Andre G.; Pols, Huibert A. P. Estrogen receptor  gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women. Arthritis & Rheumatism (2003), 48(7), 1913-1922. CODEN: ARHEAW ISSN:0004-3591. CAN 139:259400 AN 2003:612865

14. Welsh, Sarah J.; Williams, Ryan R.; Birmingham, Anne; Newman, David J.; Kirkpatrick, D. Lynn; Powis, Garth. The thioredoxin redox inhibitors 1-methylpropyl-2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1 and vascular endothelial growth factor formation. Molecular Cancer Therapeutics (2003), 2(3), 235-243. CODEN: MCTOCF ISSN:1535-7163. CAN 139:143631 AN 2003:238985

15. Husbeck, Bryan; Powis, Garth. The redox protein thioredoxin-1 regulates the constitutive and inducible expression of the estrogen metabolizing cytochromes P450 1B1 and 1A1 in MCF-7 human breast cancer cells. Carcinogenesis (2002), 23(10), 1625-1630. CODEN: CRNGDP ISSN:0143-3334. CAN 138:53510 AN 2002:799915

16. Kirkpatrick, D. Lynn; Powis, Garth; Miller, Raymond A. DNA arrays for determining drug selectivity. PCT Int. Appl. (2001), 37 pp. CODEN: PIXXD2 WO 2001061052 A1 20010823 CAN 135:175341 AN 2001:618211

17. Shirato, Yoshimi; Shimokawa, Kenji; Shimura, Mitsunori. Adsorptive separation of styrene. Jpn. Kokai Tokkyo Koho (1990), 7 pp. CODEN: JKXXAF JP 02138137 A 19900528 Heisei. CAN 113:134638 AN 1990:534638

18. Broncel Marlena; Kozirog Marzena; Duchnowicz Piotr; Koter-Michalak Maria; Sikora Joanna; Chojnowska-Jezierska Julita Aronia melanocarpa extract reduces blood pressure, serum endothelin, lipid, and oxidative stress marker levels in patients with metabolic syndrome. Medical science monitor : international medical journal of experimental and clinical research (2010), 16(1), CR28-34.

19. Bayes M; Rabasseda X; Prous J R Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology (2007), 29(5), 359-73.

20. Kiviharju Kristiina; Moilanen Ulla; Leisola Matti; Eerikainen Tero A chemostat study of Streptomyces peucetius var. caesius N47. Applied microbiology and biotechnology (2007), 73(6), 1267-74.

21. Bayes M; Rabasseda X; Prous J R Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology (2004), 26(3), 211-44.